DNLI Denali Therapeutics Inc

USD 20.77 0.89 4.476861
Icon

Denali Therapeutics Inc (DNLI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 20.77

+0.89 (+4.48)%

USD 2.73B

0.80M

USD 35.33(+70.12%)

USD 37.50 (+80.55%)

Icon

DNLI

Denali Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 20.77
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.73B

USD 37.50 (+80.55%)

USD 20.77

Denali Therapeutics Inc (DNLI) Stock Forecast

Show ratings and price targets of :
USD 35.33
(+70.12%)

Based on the Denali Therapeutics Inc stock forecast from 6 analysts, the average analyst target price for Denali Therapeutics Inc is USD 35.33 over the next 12 months. Denali Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Denali Therapeutics Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, Denali Therapeutics Inc’s stock price was USD 20.77. Denali Therapeutics Inc’s stock price has changed by -2.44% over the past week, -11.05% over the past month and -8.98% over the last year.

No recent analyst target price found for Denali Therapeutics Inc
No recent average analyst rating found for Denali Therapeutics Inc

Company Overview Denali Therapeutics Inc

Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company's transport vehicle (TV)-enabled programs ...Read More

161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

445

December

USD

USA

Adjusted Closing Price for Denali Therapeutics Inc (DNLI)

Loading...

Unadjusted Closing Price for Denali Therapeutics Inc (DNLI)

Loading...

Share Trading Volume for Denali Therapeutics Inc Shares

Loading...

Compare Performance of Denali Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for DNLI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Denali Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing DNLI

Symbol Name DNLI's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Denali Therapeutics Inc (DNLI) Stock

Based on ratings from 6 analysts Denali Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 6 buy, sell and hold ratings.

Unfortunately we do not have enough data on DNLI's stock to indicate if its a good dividend stock.

Based on targets from 6 analysts, the average taret price for DNLI is USD 35.33 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 28.

DNLI stock's Price/Earning ratio is 136.02. Our analysis grades DNLI stock's Price / Earning ratio at F. This means that DNLI stock's Price/Earning ratio is above 93% of the stocks in the Biotechnology sector in the NSD exchange. Based on this DNLI may be a overvalued for its sector.

The last closing price of DNLI's stock was USD 20.77.

The most recent market capitalization for DNLI is USD 2.73B.

Based on targets from 6 analysts, the average taret price for DNLI is projected at USD 35.33 over the next 12 months. This means that DNLI's stock price may go up by +70.12% over the next 12 months.

We can't find any ETFs which contains Denali Therapeutics Inc's stock.

As per our most recent records Denali Therapeutics Inc has 445 Employees.

Denali Therapeutics Inc's registered address is 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080. You can get more information about it from Denali Therapeutics Inc's website at https://www.denalitherapeutics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...